The treatment is currently available in around 36 countries including UK, France, Italy, Germany, Poland, The Netherlands, Spain, Australia, several South American countries, Asia and the Middle East.
Clinical trials and publications are numerous and show the same success rates across all countries
You have access to these papers in a summarised but detailed form should you wish to read or refer to them.
After undergoing the treatment several thousand patients have reported NO significant side effects.
This is to be expected given the nature of the treatment.
We encourage you to report to us anything that may be of concern however we are confident that you will not experience any negative symptoms as a result of the treatment.
If you have existing medical conditions please outline these to the doctor at the time of screening and he will access whether they are relevant to consider.